ADMA - Adma Biologics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - ADMA (1368514)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
10 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2022-12-09
ADMALenz BrianEVP, CFOP - Purchase$2.86+6,9931,034,825+1%+$20,000
2022-12-09
ADMAGrossman Adam SPres, CEOP - Purchase$2.86+29,9653,928,091+1%+$85,700
2021-10-25
ADMAKwon YoungDirP - Purchase$1.00+100,000200,000+100%+$100,000
2021-10-25
ADMAGrossman Jerrold BDirP - Purchase$1.00+100,000353,571+39%+$100,000
2021-10-25
ADMALenz BrianEVP, CFOP - Purchase$1.00+30,0001,065,501+3%+$30,000
2021-10-25
ADMAGrossman Adam SPres, CEOP - Purchase$1.00+350,0003,847,017+10%+$350,000
M
2021-09-28
ADMAPerceptive Advisors LLC10%S - Sale$1.15-260,60313,262,375-2%-$299,236
M
2021-09-24
ADMAPerceptive Advisors LLC10%S - Sale$1.25-500,00013,522,978-4%-$622,500
2021-09-23
ADMAPerceptive Advisors LLC10%S - Sale$1.27-780,00014,022,978-5%-$990,600
M
2021-08-17
ADMAPerceptive Advisors LLC10%S - Sale$1.31-1,781,82414,802,978-11%-$2,333,781

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top